HCW Biologics, Inc. HCWB 深 滬
等待開盤 05-22 09:30:00 美东时间
2.58
+0.150
+6.17%
華盛通- 最 高2.92
- 今 開2.17
- 成交量 2120.78万股
- 最 低 1.6001
- 昨 收 2.43
- 總市值 1737.40万
- 52周最高 7.825
- 市盈率 靜 --
- 換手率 314.93%
- 52周最低 0.25
- 委 比 -91.34%
- 總股本 673.41万
- 歷史最高 311.00
- 量 比 0.16
- 振 幅 54.32%
- 歷史最低 0.25
- 每 手 1
- 風險率 2.05%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多HCW Biologics Prices Private Placement Of 2.84M Units At $1.405 Each
HCW Biologics Inc. (the "Company" or "HCW Biologics"), (NASDAQ:HCWB), a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to treat autoimmune, cancer and senescence-associated
05-21 21:56
What's Going On With HCW Biologics Stock Monday?
HCW Biologics (HCWB) reports Q1 EPS of $0.37 and $6.54M in sales. Find out why the stock skyrocketed and what's next.
05-18 19:14
Why Is HCW Biologics Stock Gaining Today?
HCW Biologics shares soared Friday after the company reported stronger quarterly results, advanced a key licensing deal and reaffirmed upcoming autoimmune clinical data milestones despite ongoing going-concern risks.
05-16 01:35
Why Figma Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Figma Inc (NYSE: FIG) shares rose 10.6% in pre-market trading after beating Q1 revenue and earnings estimates and raising FY26 sales guidance.
05-15 17:38
HCW Biologics Announces Its HCW11-040 Pembrolizumab-based Fusion Immunotherapeutic Discovered To Prevent Bronchopulmonary Dysplasia During IND-Enabling Trials
HCW Biologics Inc. (the "Company" or "HCW Biologics"), (NASDAQ:HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on developing novel fusion immunotherapeutics to treat autoimmune diseases, cancer, and
05-14 19:35
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Cyclerion Therapeutics (NASDAQ:CYCN) shares rose 307.1% to $6.31 durin...
04-02 01:06
HCW Biologics shares are trading lower after the company reported a year-over-year decrease in Q4 sales results.
HCW Biologics shares are trading lower after the company reported a year-over-y...
04-01 23:38
HCW Biologics Q4 EPS $(1.02) Up From $(3.19) YoY, Sales $27.010K Down From $394.804K YoY
HCW Biologics (NASDAQ:HCWB) reported quarterly losses of $(1.02) per share. This is a 68.03 percent increase over losses of $(3.19) per share from the same period last year. The company reported $27.010 thousand in
04-01 05:19
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Fr...
03-21 05:05
HCW Biologics shares are trading higher after the company announced results for HCW9206 production platform for CAR-T cell therapies.
HCW Biologics shares are trading higher after the company announced results for...
03-16 21:27
